Capstan Therapeutics
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of Intravenous CPTX2309 in Healthy Participants and Participants With Moderate to Severe Rheumatoid Arthritis (RA) or Systemic Lupus Erythematosus (SLE) (NCT06917742) | Capstan Therapeutics | 2025-04-09 |
Track Capstan Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.